{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T20:37:17Z","timestamp":1783715837910,"version":"3.55.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"DOI":"10.1186\/s40360-025-00941-z","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T16:10:56Z","timestamp":1747930256000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Medication errors in malaria management in children: insights from pharmacovigilance data in the Democratic Republic of Congo"],"prefix":"10.1186","volume":"26","author":[{"given":"Mireille Ngale","family":"Amba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erick Kamangu","family":"Ntambwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline Engo","family":"Biongo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nsengi","family":"Ntamabyaliro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gauthier Mesia","family":"Kahunu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph Bodi","family":"Mabiala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celestin Nsibu","family":"Ndosimao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaston Tona","family":"Lutete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghada","family":"Miremont-Salam\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Fourrier-R\u00e9glat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,22]]},"reference":[{"key":"941_CR1","unstructured":"WHO. International drug monitoring: The roles of national centres. Technical Report No 498. 1972."},{"key":"941_CR2","unstructured":"National Coordinating Council for Medication Error Reporting and Prevention (NCCMERP). Defintion and types of medication errors. [Internet]. [cited 2023 Jun 23]. Available from: http:\/\/www.nccmerp.org\/about-medication-errors"},{"key":"941_CR3","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/j.1365-2125.2009.03415.x","volume":"67","author":"JK Aronson","year":"2009","unstructured":"Aronson JK. Medication errors: definitions and classification. Br J Clin Pharmacol. 2009;67:599\u2013604.","journal-title":"Br J Clin Pharmacol"},{"key":"941_CR4","doi-asserted-by":"crossref","unstructured":"Makary MA, Daniel M. Medical error-the third leading cause of death in the US. BMJ (Online). 2016;353.","DOI":"10.1136\/bmj.i2139"},{"key":"941_CR5","doi-asserted-by":"crossref","unstructured":"James JTA. New Evidence-based Estimate of Patient Harms Associated with Hospital Care [Internet]. 2013. Available from: http:\/\/oig.hhs.gov","DOI":"10.1097\/PTS.0b013e3182948a69"},{"issue":"2","key":"941_CR6","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1093\/jamia\/ocv096","volume":"23","author":"ZHA Shehata","year":"2016","unstructured":"Shehata ZHA, Sabri NA, Elmelegy AA. Descriptive analysis of medication errors reported to the Egyptian National online reporting system during six months. J Am Med Inform Assoc. 2016;23(2):366\u201374.","journal-title":"J Am Med Inform Assoc"},{"key":"941_CR7","doi-asserted-by":"crossref","unstructured":"Sheikh A, Dhingra-Kumar N, Kelley E, Kieny MP, Donaldson LJ. The third global patient safety challenge: tackling medication-related harm. Bulletin of the World Health Organization. World Health Organization; 2017;95.","DOI":"10.2471\/BLT.17.198002"},{"key":"941_CR8","unstructured":"World Health Organization. Patient safety. WHO global patient safety challenge: medication without harm [Internet]. 2017 [cited 2023 Jun 23]. Available from: http:\/\/www.who.int\/patientsafety\/medication-safety\/en\/"},{"key":"941_CR9","unstructured":"WHO. World malaria report 2024: addressing inequity in the global malaria response. Geneva: World Health Organization; 2024 Dec."},{"key":"941_CR10","unstructured":"Roll Back Malaria\/WHO. Antimalarial drug combination therapy: Report of a WHO technical consultation [Internet]. Geneva. 2001 Apr. Available from: http:\/\/www.rbm.who.int\/"},{"key":"941_CR11","unstructured":"WHO, Global Malaria Programme (GMP). Global report on antimalarial drug efficacy and drug resistance: 2000\u20132010. Geneva: World Health Organization; 2010 Nov."},{"key":"941_CR12","doi-asserted-by":"crossref","unstructured":"Dodoo ANO, Fogg C, Asiimwe A, Nartey ET, Kodua A, Tenkorang O, et al. Pattern of drug utilization for treatment of uncomplicated malaria in urban Ghana following National treatment policy change to artemisinin-combination therapy. Malar J. 2009;8(1).","DOI":"10.1186\/1475-2875-8-2"},{"issue":"4","key":"941_CR13","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.medmal.2018.02.003","volume":"48","author":"P Nkoli Mandoko","year":"2018","unstructured":"Nkoli Mandoko P, Sinou V, Moke Mbongi D, Ngoyi Mumba D, Kahunu Mesia G, Losimba Likwela J, et al. Access to artemisinin-based combination therapies and other anti-malarial drugs in Kinshasa. Med Mal Infect. 2018;48(4):269\u201377.","journal-title":"Med Mal Infect"},{"key":"941_CR14","unstructured":"WHO. Internet. 2024 [cited 2024 Dec 22]. La RDC renforce la lutte contre le paludisme chez les enfants avec le traitement pr\u00e9ventif. Available from: https:\/\/www.afro.who.int\/fr\/countries\/democratic-republic-of-congo\/news\/la-rdc-renforce-la-lutte-contre-le-paludisme-chez-les-enfants-avec-le-traitement-preventif"},{"key":"941_CR15","doi-asserted-by":"publisher","unstructured":"Kaushal R, Bates DW, Landrigan C, Mckenna KJ, Clapp MD, Federico RF, et al. Medication errors and adverse drug events in pediatric inpatients. JAMA. 2021;285(16):2114\u201320. https:\/\/doi.org\/10.1001\/jama.285.16.2114","DOI":"10.1001\/jama.285.16.2114"},{"key":"941_CR16","doi-asserted-by":"crossref","unstructured":"Fortescue EB, Kaushal R, Landrigan CP, McKenna KJ, Clapp MD, Federico F, et al. Prioritizing strategies for preventing medication errors and adverse drug events in pediatric inpatients [Internet]. 2003. Available from: www.aappublications.org\/news","DOI":"10.1542\/peds.111.4.722"},{"key":"941_CR17","doi-asserted-by":"crossref","unstructured":"Ross LM, Wallace J, Paton JY. Medication errors in a paediatric teaching hospital in the UK: five years operational experience [Internet]. Vol. 83, Arch Dis Child. 2000. Available from: www.archdischild.com","DOI":"10.1136\/adc.83.6.492"},{"key":"941_CR18","doi-asserted-by":"crossref","unstructured":"Santell JP, Hicks RW, McMeekin J, Cousins DD. Medication errors: experience of the united States pharmacopeia (USP) MEDMARX reporting system. Journal of clinical Pharmacology. SAGE Publications Inc. 2003. pp. 760\u20137.","DOI":"10.1177\/0091270003043007011"},{"key":"941_CR19","doi-asserted-by":"crossref","unstructured":"Malkawi WA, Alrafayah E, Alhazabreh M, Abulaila S, Al-Ghananeem AM. Formulation challenges and strategies to develop pediatric dosage forms. Children. Multidisciplinary Digital Publishing Institute (MDPI). 2022;9.","DOI":"10.3390\/children9040488"},{"key":"941_CR20","doi-asserted-by":"crossref","unstructured":"Horen B, Montastruc JL, Lapeyre-Mestre M. Adverse drug reactions and off-label drug use in paediatric outpatients. J Clin Pharmacol. 2002;54.","DOI":"10.1046\/j.1365-2125.2002.t01-3-01689.x"},{"issue":"1","key":"941_CR21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1080\/21556660.2019.1566137","volume":"8","author":"MD G\u00fcner","year":"2019","unstructured":"G\u00fcner MD, Ekmekci PE. Healthcare professionals\u2019 pharmacovigilance knowledge and adverse drug reaction reporting behavior and factors determining the reporting rates. J Drug Assess. 2019;8(1):13\u201320.","journal-title":"J Drug Assess"},{"key":"941_CR22","doi-asserted-by":"crossref","unstructured":"Olsson S, Pal SN, Dodoo A. Pharmacovigilance in resource-limited countries. Expert Review of Clinical Pharmacology. Expert Reviews Ltd. 2015;8:449\u201360.","DOI":"10.1586\/17512433.2015.1053391"},{"key":"941_CR23","doi-asserted-by":"crossref","unstructured":"Isah AO, Pal SN, Olsson S, Dodoo A, Bencheikh RS. Specific features of medicines safety and pharmacovigilance in Africa. Therapeutic Adv Drug Saf. 2012;3:25\u201334.","DOI":"10.1177\/2042098611425695"},{"key":"941_CR24","doi-asserted-by":"crossref","unstructured":"Almuzaini T, Choonara I, Sammons H. Substandard and counterfeit medicines: a systematic review of the literature. Open [Internet]. 2013;3:2923. Available from: http:\/\/bmjopen.bmj.com\/","DOI":"10.1136\/bmjopen-2013-002923"},{"key":"941_CR25","doi-asserted-by":"crossref","unstructured":"Eshetie TC, Hailemeskel B, Mekonnen N, Paulos G, Mekonnen AB, Girma T. Adverse drug events in hospitalized children at Ethiopian university hospital: A prospective observational study. BMC Pediatr. 2015;15(1).","DOI":"10.1186\/s12887-015-0401-0"},{"key":"941_CR26","doi-asserted-by":"crossref","unstructured":"Hilda Ampadu H, Hoekman J, Arhinful D, Amoama-Dapaah M, Leufkens HGM, Dodoo ANO. Organizational capacities of National pharmacovigilance centres in Africa: assessment of resource elements associated with successful and unsuccessful pharmacovigilance experiences. Global Health. 2018;14(1).","DOI":"10.1186\/s12992-018-0431-0"},{"key":"941_CR27","doi-asserted-by":"publisher","first-page":"204209861986485","DOI":"10.1177\/2042098619864853","volume":"10","author":"D Nzolo","year":"2019","unstructured":"Nzolo D, Kuemmerle A, Lula Y, Ntamabyaliro N, Engo A, Mvete B, et al. Development of a pharmacovigilance system in a resource-limited country: the experience of the Democratic Republic of congo. Ther Adv Drug Saf. 2019;10:204209861986485.","journal-title":"Ther Adv Drug Saf"},{"issue":"1","key":"941_CR28","doi-asserted-by":"publisher","first-page":"69","DOI":"10.11648\/j.ajbls.20210901.19","volume":"9","author":"K Katengele","year":"2021","unstructured":"Katengele K, Kiniati F, Isalomboto N, Kialengila Mana D. The potential impact of Self-medication and drug misuse practice among youth population in Kinshasa, Democratic Republic of congo. Am J Biomedical Life Sci. 2021;9(1):69.","journal-title":"Am J Biomedical Life Sci"},{"issue":"2","key":"941_CR29","doi-asserted-by":"publisher","first-page":"007","DOI":"10.30574\/gscbps.2020.12.2.0228","volume":"12","author":"BC Valentin","year":"2020","unstructured":"Valentin BC, Salvius BA. Okusa Ndjolo Philippe, Lumbu Simbi Jean-Baptiste. Self-medication with antimalarials drugs in Lubumbashi City (DR Congo). GSC Biol Pharm Sci. 2020;12(2):007\u201320.","journal-title":"GSC Biol Pharm Sci"},{"key":"941_CR30","doi-asserted-by":"crossref","unstructured":"Ntamabyaliro NY, Burri C, Lula YN, Nzolo DB, Engo AB, Ngale MA, et al. Determinants of patients\u2019 adherence to malaria treatment in the Democratic Republic of the congo. Trop Med Infect Dis. 2022;7(7).","DOI":"10.3390\/tropicalmed7070138"},{"key":"941_CR31","doi-asserted-by":"crossref","unstructured":"Muhindo Mavoko H, Ilombe G, Inoc\u00eancio D, Luz R, Kutekemeni A, Van Geertruyden JP, Lutumba P. Malaria policies versus practices, a reality check from Kinshasa, the capital of the Democratic Republic of congo. BMC Public Health. 2015;15(1).","DOI":"10.1186\/s12889-015-1670-0"},{"key":"941_CR32","doi-asserted-by":"crossref","unstructured":"Ntamabyaliro NY, Burri C, Nzolo DB, Engo AB, Lula YN, Mampunza SM, et al. Drug use in the management of uncomplicated malaria in public health facilities in the Democratic Republic of the congo. Malar J. 2018;17(1).","DOI":"10.1186\/s12936-018-2332-3"},{"key":"941_CR33","unstructured":"Uppsala Monitoring Centre. About vigibase [Internet]. [cited 2023 Oct 16]. Available from: https:\/\/who-umc.org\/vigibase\/"},{"key":"941_CR34","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology. International language for drug utilization research [Internet]. [cited 2023 Oct 18]. Available from: https:\/\/www.whocc.no\/atc_ddd_index\/?code=P01B&showdescription=no"},{"key":"941_CR35","unstructured":"Programma National de Lutte contre le Paludisme. Directives nationales de traitement du paludisme En r\u00e9publique d\u00e9mocratique du congo. Kinshasa; 2012."},{"key":"941_CR36","unstructured":"Programme national de lutte contre le paludisme. Faire reculer Le paludisme. Plan strat\u00e9gique 2007\u20132011. Kinshasa; 2007."},{"key":"941_CR37","unstructured":"Bouchez JM, Xiong M, San KM. Manuel op\u00e9rationnel pour le d\u00e9ploiement de l\u2019artesunate injectable. 2016."},{"key":"941_CR38","unstructured":"National Coordinating Council for Medication Error Reporting and Prevention (NCC MERP). About medication errors\/NCC MERP. What is a medication error? [Internet]. 2023. Available from: https:\/\/www.nccmerp.org\/about-medication-errors"},{"issue":"4","key":"941_CR39","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1179\/2046905515Y.0000000059","volume":"36","author":"K Obebi Cliff-Eribo","year":"2016","unstructured":"Obebi Cliff-Eribo K, Sammons H, Star K, Ralph Edwards I, Osakwe A, Choonara I. Adverse drug reactions in Nigerian children: a retrospective review of reports submitted to the Nigerian pharmacovigilance centre from 2005 to 2012. Paediatr Int Child Health. 2016;36(4):300\u20134.","journal-title":"Paediatr Int Child Health"},{"key":"941_CR40","doi-asserted-by":"crossref","unstructured":"Cliff-Eribo KO, Choonara I, Dodoo A, Darko DM, Sammons H. Adverse drug reactions in Ghanaian children: review of reports from 2000 to 2012 in vigibase. Expert Opinion on Drug Safety. Taylor and Francis Ltd; 2015;14:1827\u201333.","DOI":"10.1517\/14740338.2015.1096927"},{"key":"941_CR41","doi-asserted-by":"crossref","unstructured":"Ashley EA, Rini Poespoprodjo J. Treatment and prevention of malaria in children [Internet]. Lancet Child Adolesc Health. 2020;4(2). Available from: www.thelancet.com\/child-adolescent","DOI":"10.1016\/S2352-4642(20)30127-9"},{"key":"941_CR42","doi-asserted-by":"publisher","first-page":"None","DOI":"10.1016\/j.gpeds.2023.100085","volume":"6","author":"R Ranjha","year":"2023","unstructured":"Ranjha R, Singh K, Baharia RK, Mohan M, Anvikar AR, Bharti PK. Age-specific malaria vulnerability and transmission reservoir among children. Global Pediatr. 2023;6:None.","journal-title":"Global Pediatr"},{"issue":"10","key":"941_CR43","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1080\/14740338.2016.1221921","volume":"15","author":"KO Cliff-Eribo","year":"2016","unstructured":"Cliff-Eribo KO, Sammons H, Choonara I. Systematic review of paediatric studies of adverse drug reactions from pharmacovigilance databases. Expert Opin Drug Saf. 2016;15(10):1321\u20138.","journal-title":"Expert Opin Drug Saf"},{"issue":"4","key":"941_CR44","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s40272-014-0076-2","volume":"16","author":"KV Blake","year":"2014","unstructured":"Blake KV, Zaccaria C, Domergue F, La Mache E, Saint-Raymond A, Hidalgo-Simon A. Comparison between paediatric and adult suspected adverse drug reactions reported to the European medicines agency: implications for pharmacovigilance. Pediatr Drugs. 2014;16(4):309\u201319.","journal-title":"Pediatr Drugs"},{"issue":"9","key":"941_CR45","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1002\/phar.1455","volume":"34","author":"WJ Lee","year":"2014","unstructured":"Lee WJ, Lee TA, Pickard AS, Caskey RN, Schumock GT. Drugs associated with adverse events in children and adolescents. Pharmacotherapy. 2014;34(9):918\u201326.","journal-title":"Pharmacotherapy"},{"key":"941_CR46","unstructured":"Aagaard L, Weber CB, Hansen EH. Adverse drug reactions in the paediatric population in Denmark: A retrospective analysis of reports made to the Danish Medicines Agency from 1998 to. 2007."},{"key":"941_CR47","doi-asserted-by":"crossref","unstructured":"Bates I, Amexo M, Tolhurst R, Barnish G. Malaria misdiagnosis: Effects on the poor and vulnerable [Internet]. 2004;364. Available from: www.thelancet.com.","DOI":"10.1016\/S0140-6736(04)17446-1"},{"key":"941_CR48","doi-asserted-by":"crossref","unstructured":"Dedefo MG, Mitike AH, Angamo MT. Incidence and determinants of medication errors and adverse drug events among hospitalized children in West Ethiopia. BMC Pediatr. 2016;16(1).","DOI":"10.1186\/s12887-016-0619-5"},{"issue":"9","key":"941_CR49","doi-asserted-by":"publisher","first-page":"e0136545","DOI":"10.1371\/journal.pone.0136545","volume":"10","author":"S Salmasi","year":"2015","unstructured":"Salmasi S, Khan TM, Hong YH, Ming LC, Wong TW. Medication errors in the Southeast Asian countries: A systematic review. PLoS ONE. 2015;10(9):e0136545.","journal-title":"PLoS ONE"},{"issue":"Suppl 3","key":"941_CR50","first-page":"S570","volume":"86","author":"V Sangtawesin","year":"2003","unstructured":"Sangtawesin V, Kanjanapattanakul W, Srisan P, Nawasiri W, Ingchareonsunthorn P. Medication errors at queen Sirikit National Institute of child health. J Med Assoc Thai. 2003;86(Suppl 3):S570\u20135.","journal-title":"J Med Assoc Thai"},{"issue":"12","key":"941_CR51","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1007\/s00431-017-3023-8","volume":"176","author":"RM Rishoej","year":"2017","unstructured":"Rishoej RM, Almarsd\u00f3ttir AB, Christesen HT, Hallas J, Kjeldsen LJ. Medication errors in pediatric inpatients: a study based on a National mandatory reporting system. Eur J Pediatr. 2017;176(12):1697\u2013705.","journal-title":"Eur J Pediatr"},{"issue":"6","key":"941_CR52","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.jsps.2017.01.001","volume":"25","author":"R Al-Ramahi","year":"2017","unstructured":"Al-Ramahi R, Hmedat B, Alnjajrah E, Manasrah I, Radwan I, Alkhatib M. Medication dosing errors and associated factors in hospitalized pediatric patients from the South area of the West Bank - Palestine. Saudi Pharm J. 2017;25(6):857\u201360.","journal-title":"Saudi Pharm J"},{"key":"941_CR53","doi-asserted-by":"crossref","unstructured":"Neuspiel DR, Taylor MM. Reducing the risk of harm from medication errors in children. Health Services Insights. SAGE Publications Ltd; 2013;6.","DOI":"10.4137\/HSI.S10454"},{"key":"941_CR54","first-page":"158","volume":"14","author":"GM Binti Dunia","year":"2013","unstructured":"Binti Dunia GM. Implantation des sites de Soins communautaires En r\u00e9publique d\u00e9mocratique du congo: cons\u00e9cration D\u2019un double standard Dans L\u2019acc\u00e8s aux Soins. Pan Afr Med J. 2013;14:158.","journal-title":"Pan Afr Med J"},{"key":"941_CR55","unstructured":"Groupe FPwatch. Document de r\u00e9f\u00e9rence de l\u2019\u00e9tude FPwatch: La R\u00e9publique D\u00e9mocratique du Congo 2015. Washington DC:PSI; 2016."},{"issue":"1","key":"941_CR56","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1136\/qhc.11.1.7","volume":"11","author":"J Firth-Cozens","year":"2002","unstructured":"Firth-Cozens J. Barriers to incident reporting. BMJ Qual Saf Health Care. 2002;11(1):7.","journal-title":"BMJ Qual Saf Health Care"},{"issue":"9","key":"941_CR57","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3390\/medicines8090046","volume":"8","author":"A Mutair","year":"2021","unstructured":"Mutair A, Al, Alhumaid S, Shamsan A, Zaidi ARZ, Mohaini M, Al A, Mutairi A, et al. The effective strategies to avoid medication errors and improving reporting systems. Medicines. 2021;8(9):46.","journal-title":"Medicines"},{"key":"941_CR58","doi-asserted-by":"crossref","unstructured":"Sabblah GT, Seaneke SK, Kushitor M, van Hunsel F, Taxis K, Duwiejua M, et al. Evaluation of pharmacovigilance systems for reporting medication errors in Africa and the role of patients using a mixed-methods approach. PLoS ONE. 2022;17(3 March).","DOI":"10.1371\/journal.pone.0264699"},{"key":"941_CR59","unstructured":"Ministry of Health. Guidelines on the pharmacovigilance in the Democratic Republic of the Congo. Kinshasa; 2018 Oct."},{"key":"941_CR60","doi-asserted-by":"crossref","unstructured":"Ndagije HB, Walusimbi D, Atuhaire J, Ampaire S. Drug safety in Africa: a review of systems and resources for pharmacovigilance. Expert Opinion on Drug Safety. Taylor and Francis Ltd.; 2023;22:891\u20135.","DOI":"10.1080\/14740338.2023.2251375"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-025-00941-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40360-025-00941-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-025-00941-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T16:11:11Z","timestamp":1747930271000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpharmacoltoxicol.biomedcentral.com\/articles\/10.1186\/s40360-025-00941-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,22]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["941"],"URL":"https:\/\/doi.org\/10.1186\/s40360-025-00941-z","relation":{},"ISSN":["2050-6511"],"issn-type":[{"value":"2050-6511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,22]]},"assertion":[{"value":"27 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"108"}}